Significance of palmitoylation of CD81 on its association with tetraspanin-enriched microdomains and mediating hepatitis C virus cell entry (Q39353391)

11 September 2017

Significance of palmitoylation of CD81 on its association with tetraspanin-enriched microdomains and mediating hepatitis C virus cell entry (English)

1 reference

11 September 2017

1 reference

1 reference

12

Zhong-Tian Qi

1 reference

11 September 2017

Yong-Zhe Zhu

1

1 reference

11 September 2017

Yuan Luo

2

1 reference

11 September 2017

Ming-Mei Cao

3

1 reference

11 September 2017

Yuan Liu

4

1 reference

11 September 2017

Xiao-Qing Liu

5

1 reference

11 September 2017

Wen Wang

6

1 reference

11 September 2017

Da-Ge Wu

7

1 reference

11 September 2017

Mo Guan

8

1 reference

11 September 2017

Qing-Qiang Xu

9

1 reference

11 September 2017

Hao Ren

10

1 reference

11 September 2017

Ping Zhao

11

1 reference

11 September 2017

language of work or name

English

0 references

publication date

4 May 2012

1 reference

11 September 2017

1 reference

11 September 2017

429

1 reference

11 September 2017

2

1 reference

11 September 2017

112-123

1 reference

Viral and Cellular Determinants of the Hepatitis C Virus Envelope-Heparan Sulfate Interaction

11 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Infectious hepatitis C virus pseudo-particles containing functional E1-E2 envelope protein complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Expression of the palmitoylation-deficient CD151 weakens the association of alpha 3 beta 1 integrin with the tetraspanin-enriched microdomains and affects integrin-dependent signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Different Domains of CD81 Mediate Distinct Stages of Hepatitis C Virus Pseudoparticle Entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

CD81 Is a Central Regulator of Cellular Events Required for Hepatitis C Virus Infection of Human Hepatocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

HIV entry in macrophages is dependent on intact lipid rafts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

The major CD9 and CD81 molecular partner. Identification and characterization of the complexes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Differential stability of tetraspanin/tetraspanin interactions: role of palmitoylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

EWI-2 is a new component of the tetraspanin web in hepatocytes and lymphoid cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

The Ig domain protein CD9P-1 down-regulates CD81 ability to support Plasmodium yoelii infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Mutation of juxtamembrane cysteines in the tetraspanin CD81 affects palmitoylation and alters interaction with other proteins at the cell surface

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Signalling functions of protein palmitoylation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Functional characterization of intracellular and secreted forms of a truncated hepatitis C virus E2 glycoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Diverse CD81 Proteins Support Hepatitis C Virus Infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Tetraspanins CD9 and CD81 modulate HIV-1-induced membrane fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Claudin association with CD81 defines hepatitis C virus entry.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Specific tetraspanin functions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Targeting of tetraspanin proteins--potential benefits and strategies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Palmitoylation supports the association of tetraspanin CD63 with CD9 and integrin alphaIIbbeta3 in activated platelets.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Initiation of hepatitis C virus infection is dependent on cholesterol and cooperativity between CD81 and scavenger receptor B type I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Evidence for specific tetraspanin homodimers: inhibition of palmitoylation makes cysteine residues available for cross-linking

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

A novel cysteine cross-linking method reveals a direct association between claudin-1 and tetraspanin CD9.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

New insights into the mechanisms of protein palmitoylation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Protein-protein interactions in the tetraspanin web.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

CD46 (membrane cofactor protein) associates with multiple β1 integrins and tetraspans

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Lipid rafts are involved in SARS-CoV entry into Vero E6 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

West Nile Virus Entry Requires Cholesterol-Rich Membrane Microdomains and Is Independent of v 3 Integrin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Polarization Restricts Hepatitis C Virus Entry into HepG2 Hepatoma Cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Serum-Derived Hepatitis C Virus Infection of Primary Human Hepatocytes Is Tetraspanin CD81 Dependent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Interacting regions of CD81 and two of its partners, EWI-2 and EWI-2wint, and their effect on hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Interaction of CD82 tetraspanin proteins with HTLV-1 envelope glycoproteins inhibits cell-to-cell fusion and virus transmission.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Human occludin is a hepatitis C virus entry factor required for infection of mouse cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Fatty acylation of proteins: new insights into membrane targeting of myristoylated and palmitoylated proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

The CD81 Partner EWI-2wint Inhibits Hepatitis C Virus Entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

The association of CD81 with tetraspanin-enriched microdomains is not essential for Hepatitis C virus entry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Subcellular localization of hepatitis C virus structural proteins in a cell culture system that efficiently replicates the virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

EWI-2 and EWI-F link the tetraspanin web to the actin cytoskeleton through their direct association with ezrin-radixin-moesin proteins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Implication of tetraspanin-enriched microdomains (TEMs) in hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Interaction of influenza virus haemagglutinin with sphingolipid-cholesterol membrane domains via its transmembrane domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Complete predicted three-dimensional structure of the facilitator transmembrane protein and hepatitis C virus receptor CD81: conserved and variable structural domains in the tetraspanin superfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

The tetraspanin CD9 associates with transmembrane TGF-alpha and regulates TGF-alpha-induced EGF receptor activation and cell proliferation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Building of the tetraspanin web: distinct structural domains of CD81 function in different cellular compartments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Cholesterol contributes to the organization of tetraspanin-enriched microdomains and to CD81-dependent infection by malaria sporozoites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Clathrin- and caveolin-independent entry of human papillomavirus type 16--involvement of tetraspanin-enriched microdomains (TEMs)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Hepatitis C virus entry and neutralization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

EWI-2 is a major CD9 and CD81 partner and member of a novel Ig protein subfamily

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Tupaia CD81, SR-BI, claudin-1, and occludin support hepatitis C virus infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Palmitoylation of caveolin-1 is required for cholesterol binding, chaperone complex formation, and rapid transport of cholesterol to caveolae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Production of infectious hepatitis C virus in tissue culture from a cloned viral genome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Direct extracellular contact between integrin alpha(3)beta(1) and TM4SF protein CD151.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Tetraspanin proteins as organisers of membrane microdomains and signalling complexes.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus and Host

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2012.03.002

10.1016/J.VIROL.2012.03.002

7 January 2021

Identifiers

DOI

1 reference

11 September 2017

1 reference